Shareholders Equity: The sum of preferred and common equity items.
Cellyan Biotechnology Co., Ltd (HKPD) had Shareholders Equity of $4.99M for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
$20.31M |
|
$-0.03M |
|
$17.90M |
|
$2.42M |
|
$20.18M |
|
$0.13M |
|
$-0.10M |
|
$0.04M |
|
$0.04M |
|
$-0.03M |
|
$-0.03M |
|
$-0.03M |
|
$-0.03M |
|
$0.13M |
|
$0.21M |
|
10.21M |
|
10.21M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$8.73M |
|
$0.11M |
|
$0.69M |
|
$9.42M |
|
$2.92M |
|
$1.51M |
|
$1.51M |
|
$4.43M |
|
$4.99M |
|
$4.89M |
|
|
Shareholders Equity |
$4.99M |
11.00M |
|
| Cash Flow Statement Financials | |
$0.57M |
|
$-2.46M |
|
$2.00M |
|
$0.63M |
|
$0.75M |
|
$0.12M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.99 |
|
-- |
|
-- |
|
0.23 |
|
0.48 |
|
11.89% |
|
0.65% |
|
0.65% |
|
1.02% |
|
0.18% |
|
-0.13% |
|
$0.50M |
|
-- |
|
-- |
|
-- |
|
2.16 |
|
31.96 |
|
3.94 |
|
92.74 |
|
-0.54% |
|
-0.55% |
|
-0.29% |
|
-0.42% |
|
$0.45 |
|
$0.05 |
|
$0.06 |
|